152 related articles for article (PubMed ID: 11533861)
1. [Strategies of long-term medication in schizophrenia].
Gaebel W
Fortschr Neurol Psychiatr; 2001 Sep; 69 Suppl 2():S113-9. PubMed ID: 11533861
[TBL] [Abstract][Full Text] [Related]
2. [Long-term medication in schizophrenic psychoses].
Gaebel W
Fortschr Neurol Psychiatr; 2000 Apr; 68 Suppl 1():S26-31. PubMed ID: 10907610
[TBL] [Abstract][Full Text] [Related]
3. Relapse prevention and recovery in the treatment of schizophrenia.
Schooler NR
J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of antipsychotic drugs and family therapies in the maintenance treatment of schizophrenia.
Schooler NR
J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):11S-19S. PubMed ID: 2870086
[TBL] [Abstract][Full Text] [Related]
5. Maintaining symptom control: review of ziprasidone long-term efficacy data.
Schooler NR
J Clin Psychiatry; 2003; 64 Suppl 19():26-32. PubMed ID: 14728087
[TBL] [Abstract][Full Text] [Related]
6. Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies.
Kane JM
J Clin Psychiatry; 2003; 64 Suppl 16():34-40. PubMed ID: 14680417
[TBL] [Abstract][Full Text] [Related]
7. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
Turner MS; Stewart DW
J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
Gaebel W; Möller HJ; Buchkremer G; Ohmann C; Riesbeck M; Wölwer W; Von Wilmsdorff M; Bottlender R; Klingberg S
Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):129-40. PubMed ID: 15146342
[TBL] [Abstract][Full Text] [Related]
9. [Lifelong relapse prevention with antipsychotics in schizophrenia].
Hasan A; Wobrock T
Psychiatr Prax; 2010 Sep; 37(6):268-70. PubMed ID: 20803409
[No Abstract] [Full Text] [Related]
10. Partial compliance in schizophrenia and the impact on patient outcomes.
Llorca PM
Psychiatry Res; 2008 Nov; 161(2):235-47. PubMed ID: 18849080
[TBL] [Abstract][Full Text] [Related]
11. [Longterm treatment of schizophrenia].
Pajonk VF
MMW Fortschr Med; 2006 Jan; 148(4):35-8. PubMed ID: 16502798
[TBL] [Abstract][Full Text] [Related]
12. Integration of family and drug treatment strategies in the treatment of schizophrenia: a selective review.
Schooler NR
Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():73-80. PubMed ID: 8866768
[TBL] [Abstract][Full Text] [Related]
13. Treatment strategies to prevent relapse and encourage remission.
Kane JM
J Clin Psychiatry; 2007; 68 Suppl 14():27-30. PubMed ID: 18284275
[TBL] [Abstract][Full Text] [Related]
14. Strategies for the long-term treatment of schizophrenia: real-world lessons from the CATIE trial.
Meyer JM
J Clin Psychiatry; 2007; 68 Suppl 1():28-33. PubMed ID: 17286525
[TBL] [Abstract][Full Text] [Related]
15. Mental health practitioner's attitude towards maintenance neuroleptic treatment for people with schizophrenia.
Harris N; Lovell K; Day JC
J Psychiatr Ment Health Nurs; 2007 Apr; 14(2):113-9. PubMed ID: 17352772
[TBL] [Abstract][Full Text] [Related]
16. Clozapine maintenance therapy in schizophrenia.
Gaszner P; Makkos Z
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
[TBL] [Abstract][Full Text] [Related]
17. [Influence of treatment course on the success of psychopharmacotherapy].
Gaebel W
Psychiatr Prax; 1985 Jan; 12(1):13-8. PubMed ID: 2858897
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment.
Altamura AC; Bobo WV; Meltzer HY
Int Clin Psychopharmacol; 2007 Sep; 22(5):249-67. PubMed ID: 17690594
[TBL] [Abstract][Full Text] [Related]
19. Optimisation of long-term treatment in schizophrenia: treating the true spectrum of symptoms.
Kasper S
Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S135-41. PubMed ID: 16872809
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]